JPS4939257B1 - - Google Patents

Info

Publication number
JPS4939257B1
JPS4939257B1 JP47064563A JP6456372A JPS4939257B1 JP S4939257 B1 JPS4939257 B1 JP S4939257B1 JP 47064563 A JP47064563 A JP 47064563A JP 6456372 A JP6456372 A JP 6456372A JP S4939257 B1 JPS4939257 B1 JP S4939257B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP47064563A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4939257B1 publication Critical patent/JPS4939257B1/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • C07C53/136Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems
    • C07C53/138Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems containing an adamantane ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/38Acyl halides
    • C07C53/44Acyl halides containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/36Acyl halides
    • C07C55/38Acyl halides containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Pivots And Pivotal Connections (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
JP47064563A 1968-08-27 1972-06-29 Pending JPS4939257B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40968/68A GB1274652A (en) 1968-08-27 1968-08-27 Adamantanyl-alkylamine derivatives and their preparation

Publications (1)

Publication Number Publication Date
JPS4939257B1 true JPS4939257B1 (en) 1974-10-24

Family

ID=10417493

Family Applications (3)

Application Number Title Priority Date Filing Date
JP47064561A Pending JPS5010856B1 (en) 1968-08-27 1972-06-29
JP47064563A Pending JPS4939257B1 (en) 1968-08-27 1972-06-29
JP47064562A Pending JPS4939256B1 (en) 1968-08-27 1972-06-29

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP47064561A Pending JPS5010856B1 (en) 1968-08-27 1972-06-29

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP47064562A Pending JPS4939256B1 (en) 1968-08-27 1972-06-29

Country Status (12)

Country Link
JP (3) JPS5010856B1 (en)
AT (1) AT307380B (en)
BE (1) BE737975A (en)
CH (3) CH553149A (en)
DE (1) DE1943404A1 (en)
DK (1) DK131721C (en)
FR (1) FR2016468B1 (en)
GB (1) GB1274652A (en)
IE (1) IE33929B1 (en)
IL (1) IL32892A (en)
NL (1) NL6913046A (en)
SE (1) SE364037B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS507356A (en) * 1973-05-22 1975-01-25

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0013737D0 (en) 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
SE0103836D0 (en) * 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
SE0300480D0 (en) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
ITTO20030668A1 (en) 2003-09-02 2005-03-03 Rotta Res Lab S P A O Ra Rottapharm DERIVATIVES OF ADAMANTAN EQUIPPED WITH NEUROPROTECTIVE, ANTIDEPRESSIVE AND ANTI-ISCHEMIC ACTIVITY AND PROCEDURE FOR THEIR PREPARATION.
WO2008114002A1 (en) 2007-03-22 2008-09-25 Astrazeneca Ab Quinoline derivatives for the treatment of inflammatory diseases
PE20091036A1 (en) 2007-11-30 2009-08-15 Astrazeneca Ab QUINOLINE DERIVATIVE AS ANTAGONIST OF THE P2X7 RECEPTOR
CN109593042B (en) * 2018-12-24 2021-12-07 陕西莱特迈思光电材料有限公司 Organic electroluminescent material and organic electroluminescent device comprising same
CN114181091A (en) * 2021-12-27 2022-03-15 苏州久显新材料有限公司 Synthesis process of adamantane triphenylamine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS507356A (en) * 1973-05-22 1975-01-25

Also Published As

Publication number Publication date
IE33929B1 (en) 1974-12-11
GB1274652A (en) 1972-05-17
IE33929L (en) 1970-02-27
DK131721C (en) 1976-01-26
NL6913046A (en) 1970-03-03
JPS4939256B1 (en) 1974-10-24
CH538442A (en) 1973-06-30
BE737975A (en) 1970-02-26
CH553149A (en) 1974-08-30
IL32892A (en) 1975-04-25
FR2016468A1 (en) 1970-05-08
JPS5010856B1 (en) 1975-04-24
DE1943404A1 (en) 1970-12-17
SE364037B (en) 1974-02-11
DK131721B (en) 1975-08-25
AT307380B (en) 1973-05-25
CH551365A (en) 1974-07-15
IL32892A0 (en) 1969-11-12
FR2016468B1 (en) 1973-06-08

Similar Documents

Publication Publication Date Title
AU428130B2 (en)
AU5184069A (en)
FR2016468B1 (en)
AU429879B2 (en)
AU2581067A (en)
AU4304568A (en)
AU4811568A (en)
AU421558B1 (en)
AU4744468A (en)
BE727853A (en)
BE709479A (en)
BE727869A (en)
BE727800A (en)
BE726947A (en)
AU479393A (en)
BE727899A (en)
BE726350A (en)
BE726344A (en)
AU4558658A (en)
BE724873A (en)
BE728537A (en)
AU4503667A (en)
BE724358A (en)
BE721248A (en)
BE716268A (en)